By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
Kite Pharma (KITE) Reports Third Quarter 2015 Financial Results And Provides Business Update 11/13/2015 8:03:56 AM
Kite Pharma (KITE) To Host Third Quarter 2015 Financial Results Conference Call And Webcast 11/10/2015 7:53:43 AM
Kite Pharma (KITE) Initiates Phase II Clinical Study Of KTE-C19 (ZUMA-2) In Patients With Relapsed Or Refractory Mantle Cell Lymphoma (R/R MCL) To Support Registration For A Second Indication 11/9/2015 7:26:07 AM
Kite Pharma (KITE) To Present Four Abstracts, Including Safety And Efficacy Data From The KTE-C19 Phase I Study In Patients With Refractory, Aggressive NHL (ZUMA-1), At The 57th American Society of Hematology Annual Meeting 11/5/2015 8:10:59 AM
Kite Pharma (KITE) To Present At Upcoming Investor Conferences In November 2015 11/4/2015 8:16:18 AM
Kite Pharma (KITE) Initiates ZUMA-1 Phase II In Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma (NHL) To Support Registration Of KTE-C19 11/2/2015 7:33:53 AM
Onco-Immunology Companies like Juno (JUNO), Novartis AG (NVS), Kite Pharma (KITE) Struggle to Mass Produce Custom Cancer Therapies 10/30/2015 6:14:24 AM
SoCal's Kite Pharma (KITE) Strikes Cancer Deal Worth $535 Million+ with Alpine Immune Sciences 10/27/2015 7:30:14 AM
Kite Pharma (KITE) Announces Exclusive License With The NIH For T Cell Receptor (TCR)-Based Products To Treat Tumors Expressing MAGE 10/20/2015 7:27:30 AM
Kite Pharma (KITE) Receives Positive Opinions For Orphan Drug Designation In The European Union (EU) For KTE-C19 In Three Additional Hematological Indications 10/15/2015 7:40:11 AM